To further rule out the potentially compensatory effects of COX-2 gene deficiency in mice following stroke, we also investigated the effects of CAY10404, a highly selective COX-2 inhibitor, on BBB damage, hemorrhagic transformation, and MMP-9 activity in wild-type mice subjected to focal ischemia. This evidence concerns the gene PTGS2 and Stroke.